Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
The Year in Patent Reform
The real legacy of the Hatch-Waxman Act
Why Current Legislation to Prevent Patent Thickets Are a Good Start — But Not Enough
The Senate HELP Committee Takes Aim at Drug Patent Abuse
Why Patent Reform Is the One Thing Democrats and Republicans Are Agreeing On
Patent Abuse is Front-Page News
Blueprint to Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices
How Egregious Orange Book Manipulation Extended an Insulin Monopoly
Our New Study: The Burden of Patent Thickets
Medicare Negotiation and the Momentum for Patent Reform